| ISIN | CH0113817040 |
|---|---|
| Valor Number | 11381704 |
| Bloomberg Global ID | BBG000WHWM84 |
| Fund Name | Bellevue Medtech & Services DT CHF |
| Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fund Provider | Bellevue Asset Management AG |
| Representative in Switzerland | |
| Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | Special conditions apply to the issue of units |
| Redemption Condition | Special conditions apply to the redemption of units |
| Investment Strategy *** | n.a. |
| Peculiarities |
| Current Price * | 3,168.34 CHF | 18.12.2025 |
|---|---|---|
| Previous Price * | 3,169.90 CHF | 17.12.2025 |
| 52 Week High * | 4,063.54 CHF | 03.02.2025 |
| 52 Week Low * | 2,943.01 CHF | 06.08.2025 |
| NAV * | 3,168.34 CHF | 18.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 55,798,740 | |
| Unit/Share Assets *** | 36,622,070 | |
| Trading Information SIX | ||
| YTD Performance | -13.07% |
31.12.2024 - 18.12.2025
31.12.2024 18.12.2025 |
|---|---|---|
| 1 month | -0.94% |
18.11.2025 - 18.12.2025
18.11.2025 18.12.2025 |
| 3 months | +3.64% |
18.09.2025 - 18.12.2025
18.09.2025 18.12.2025 |
| 6 months | -0.09% |
18.06.2025 - 18.12.2025
18.06.2025 18.12.2025 |
| 1 year | -11.27% |
18.12.2024 - 18.12.2025
18.12.2024 18.12.2025 |
| 2 years | -6.35% |
18.12.2023 - 18.12.2025
18.12.2023 18.12.2025 |
| 3 years | -14.12% |
19.12.2022 - 18.12.2025
19.12.2022 18.12.2025 |
| 5 years | -3.06% |
18.12.2020 - 18.12.2025
18.12.2020 18.12.2025 |
| Equity Participation Rate in % | 98.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | 1.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | 18.12.2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UnitedHealth Group Inc | 15.13% | |
|---|---|---|
| Abbott Laboratories | 11.91% | |
| Intuitive Surgical Inc | 10.52% | |
| Boston Scientific Corp | 9.00% | |
| Stryker Corp | 8.46% | |
| Medtronic PLC | 5.51% | |
| HCA Healthcare Inc | 4.97% | |
| McKesson Corp | 3.85% | |
| The Cigna Group | 3.58% | |
| Veeva Systems Inc Class A | 3.47% | |
| Last data update | 31.10.2025 | |
| TER | 1.25% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |